Gentamicin and amikacin adversely affect male infertility indicated by pharmacological, andrological and pathological evidence
International Journal of Basic & Clinical Pharmacology • 2020
معلومات البحث
المؤلفون
Hozaifa K. Elsawah, Mohamed M. Kandiel, Aziza A. Amin, Haitham M. Mokhimar, AbuBakr M. El Mahmoudy
الكلمات المفتاحية
Gentamicin, Amikacin, Hormone, Testis, Sperm, Reproduction
المجلة العلمية
International Journal of Basic & Clinical Pharmacology
الناشر
Not Available
المجلد
9
العدد
2
الصفحات
218-225
publication.type
International
رابط البحث
Not Available
المواد المرفقة
Not Available
الملخص
Background: Many drugs are implicated in male infertility and screening for medication history is an important for diagnosis and treatment of the problem. The aim is to study amikacin effect on male reproductive system in comparison to gentamicin.
Methods: Twenty-five male wister rats weighted 220±20 gm and aged 8 weeks were randomly divided into five groups of five. The first group received gentamicin in dose 18.25 mg/kg/day once daily (OD) (therapeutic dose). The second group received gentamicin with double dose of the first group. The third group received amikacin in dose 54.75 mg/kg/day OD (therapeutic dose). The Fourth group received amikacin with double dose of the third group. However, the fifth group served as a control and received normal saline (NS) OD. All treatments were administered intraperitoneally (IP) for 14 days. On the 15th day, blood samples and reproductive organs were obtained from all animals. Testicular tissues were prepared for genetic testing and chemical and microscopical examination.
Results: Amikacin and gentamicin negatively affected reproductive organs weights, sperm parameters, serum follicle stimulating hormone and luteinizing hormone (LH) level relative to control (p
Methods: Twenty-five male wister rats weighted 220±20 gm and aged 8 weeks were randomly divided into five groups of five. The first group received gentamicin in dose 18.25 mg/kg/day once daily (OD) (therapeutic dose). The second group received gentamicin with double dose of the first group. The third group received amikacin in dose 54.75 mg/kg/day OD (therapeutic dose). The Fourth group received amikacin with double dose of the third group. However, the fifth group served as a control and received normal saline (NS) OD. All treatments were administered intraperitoneally (IP) for 14 days. On the 15th day, blood samples and reproductive organs were obtained from all animals. Testicular tissues were prepared for genetic testing and chemical and microscopical examination.
Results: Amikacin and gentamicin negatively affected reproductive organs weights, sperm parameters, serum follicle stimulating hormone and luteinizing hormone (LH) level relative to control (p
أعضاء هيئة التدريس - جامعة بنها